NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $784,253 | +27093.2% | 16,117 | -77.6% | 0.01% | -84.2% |
Q4 2022 | $2,884 | -99.9% | 71,799 | +62.4% | 0.06% | +35.7% |
Q3 2022 | $1,937,000 | +66.3% | 44,206 | +54.3% | 0.04% | +55.6% |
Q1 2022 | $1,165,000 | +439.4% | 28,641 | +1377.9% | 0.03% | +575.0% |
Q3 2021 | $216,000 | -98.0% | 1,938 | -98.0% | 0.00% | -98.1% |
Q2 2021 | $10,927,000 | +459.2% | 96,250 | +400.3% | 0.21% | +428.2% |
Q1 2021 | $1,954,000 | -60.4% | 19,240 | -61.2% | 0.04% | -72.1% |
Q4 2020 | $4,938,000 | +213.7% | 49,620 | +127.8% | 0.14% | +105.9% |
Q3 2020 | $1,574,000 | +1159.2% | 21,786 | +111.1% | 0.07% | +2166.7% |
Q2 2016 | $125,000 | +27.6% | 10,321 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $98,000 | – | 10,321 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |